Report Detail

Request for Sample of this report

Pharma & Healthcare Global Onychomycosis (Tinea Unguium) Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4713868
    • |
  • 29 June, 2026
    • |
  • Global
    • |
  • 111 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Onychomycosis (Tinea Unguium) Drug market size was valued at US$ 3981 million in 2025 and is forecast to a readjusted size of US$ 5830 million by 2032 with a CAGR of 5.7% during review period.
Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.
Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.
Global Onychomycosis (Tinea Unguium) Drug key players include Pfizer, J&J, Novartis, Galderma pharm, Valeant Pharma, etc. Global top five manufacturers hold a share about 35%.
North America is the largest market, with a share about 30%, followed by Europe and China both have a share over 45 percent.
In terms of product, Oral Medication is the largest segment, with a share over 70%. And in terms of application, the largest application is Age above 50, followed by Age under 18.
This report is a detailed and comprehensive analysis for global Onychomycosis (Tinea Unguium) Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Onychomycosis (Tinea Unguium) Drug market size and forecasts, in consumption value ($ Million), 2021-2032
Global Onychomycosis (Tinea Unguium) Drug market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Onychomycosis (Tinea Unguium) Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Onychomycosis (Tinea Unguium) Drug market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Onychomycosis (Tinea Unguium) Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Onychomycosis (Tinea Unguium) Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Yangtze River, Torrent Pharma, J&J, Chengdu Brilliant, Novartis, Qilu Pharmaceutical, Xiuzheng Pharmaceutical, Hubei Hengan, TARO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Onychomycosis (Tinea Unguium) Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral Medication
External Medicine
Market segment by Application
Age under 18
Age 18-50
Age above 50
Market segment by players, this report covers
Pfizer
Yangtze River
Torrent Pharma
J&J
Chengdu Brilliant
Novartis
Qilu Pharmaceutical
Xiuzheng Pharmaceutical
Hubei Hengan
TARO
Perrigo
Galderma pharm
Zhejiang Deyer
Valeant Pharma
Moberg
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Onychomycosis (Tinea Unguium) Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Onychomycosis (Tinea Unguium) Drug, with revenue, gross margin, and global market share of Onychomycosis (Tinea Unguium) Drug from 2021 to 2026.
Chapter 3, the Onychomycosis (Tinea Unguium) Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Onychomycosis (Tinea Unguium) Drug market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Onychomycosis (Tinea Unguium) Drug.
Chapter 13, to describe Onychomycosis (Tinea Unguium) Drug research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Onychomycosis (Tinea Unguium) Drug by Type
    • 1.3.1 Overview: Global Onychomycosis (Tinea Unguium) Drug Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Type in 2025
    • 1.3.3 Oral Medication
    • 1.3.4 External Medicine
  • 1.4 Global Onychomycosis (Tinea Unguium) Drug Market by Application
    • 1.4.1 Overview: Global Onychomycosis (Tinea Unguium) Drug Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Age under 18
    • 1.4.3 Age 18-50
    • 1.4.4 Age above 50
  • 1.5 Global Onychomycosis (Tinea Unguium) Drug Market Size & Forecast
  • 1.6 Global Onychomycosis (Tinea Unguium) Drug Market Size and Forecast by Region
    • 1.6.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region, (2021-2032)
    • 1.6.3 North America Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2021-2032)
    • 1.6.6 South America Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.1.4 Pfizer Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments and Future Plans
  • 2.2 Yangtze River
    • 2.2.1 Yangtze River Details
    • 2.2.2 Yangtze River Major Business
    • 2.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.2.4 Yangtze River Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Yangtze River Recent Developments and Future Plans
  • 2.3 Torrent Pharma
    • 2.3.1 Torrent Pharma Details
    • 2.3.2 Torrent Pharma Major Business
    • 2.3.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.3.4 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Torrent Pharma Recent Developments and Future Plans
  • 2.4 J&J
    • 2.4.1 J&J Details
    • 2.4.2 J&J Major Business
    • 2.4.3 J&J Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.4.4 J&J Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 J&J Recent Developments and Future Plans
  • 2.5 Chengdu Brilliant
    • 2.5.1 Chengdu Brilliant Details
    • 2.5.2 Chengdu Brilliant Major Business
    • 2.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.5.4 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Chengdu Brilliant Recent Developments and Future Plans
  • 2.6 Novartis
    • 2.6.1 Novartis Details
    • 2.6.2 Novartis Major Business
    • 2.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.6.4 Novartis Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Novartis Recent Developments and Future Plans
  • 2.7 Qilu Pharmaceutical
    • 2.7.1 Qilu Pharmaceutical Details
    • 2.7.2 Qilu Pharmaceutical Major Business
    • 2.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.7.4 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Qilu Pharmaceutical Recent Developments and Future Plans
  • 2.8 Xiuzheng Pharmaceutical
    • 2.8.1 Xiuzheng Pharmaceutical Details
    • 2.8.2 Xiuzheng Pharmaceutical Major Business
    • 2.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.8.4 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Xiuzheng Pharmaceutical Recent Developments and Future Plans
  • 2.9 Hubei Hengan
    • 2.9.1 Hubei Hengan Details
    • 2.9.2 Hubei Hengan Major Business
    • 2.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.9.4 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Hubei Hengan Recent Developments and Future Plans
  • 2.10 TARO
    • 2.10.1 TARO Details
    • 2.10.2 TARO Major Business
    • 2.10.3 TARO Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.10.4 TARO Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 TARO Recent Developments and Future Plans
  • 2.11 Perrigo
    • 2.11.1 Perrigo Details
    • 2.11.2 Perrigo Major Business
    • 2.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.11.4 Perrigo Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Perrigo Recent Developments and Future Plans
  • 2.12 Galderma pharm
    • 2.12.1 Galderma pharm Details
    • 2.12.2 Galderma pharm Major Business
    • 2.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.12.4 Galderma pharm Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Galderma pharm Recent Developments and Future Plans
  • 2.13 Zhejiang Deyer
    • 2.13.1 Zhejiang Deyer Details
    • 2.13.2 Zhejiang Deyer Major Business
    • 2.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.13.4 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Zhejiang Deyer Recent Developments and Future Plans
  • 2.14 Valeant Pharma
    • 2.14.1 Valeant Pharma Details
    • 2.14.2 Valeant Pharma Major Business
    • 2.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.14.4 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Valeant Pharma Recent Developments and Future Plans
  • 2.15 Moberg
    • 2.15.1 Moberg Details
    • 2.15.2 Moberg Major Business
    • 2.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Product and Solutions
    • 2.15.4 Moberg Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Moberg Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Onychomycosis (Tinea Unguium) Drug Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Onychomycosis (Tinea Unguium) Drug by Company Revenue
    • 3.2.2 Top 3 Onychomycosis (Tinea Unguium) Drug Players Market Share in 2025
    • 3.2.3 Top 6 Onychomycosis (Tinea Unguium) Drug Players Market Share in 2025
  • 3.3 Onychomycosis (Tinea Unguium) Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Onychomycosis (Tinea Unguium) Drug Market: Region Footprint
    • 3.3.2 Onychomycosis (Tinea Unguium) Drug Market: Company Product Type Footprint
    • 3.3.3 Onychomycosis (Tinea Unguium) Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Onychomycosis (Tinea Unguium) Drug Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2021-2032)
  • 6.2 North America Onychomycosis (Tinea Unguium) Drug Market Size by Application (2021-2032)
  • 6.3 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country
    • 6.3.1 North America Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2021-2032)
    • 6.3.2 United States Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2021-2032)
  • 7.2 Europe Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2021-2032)
  • 7.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country
    • 7.3.1 Europe Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)
    • 7.3.3 France Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region
    • 8.3.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value by Region (2021-2032)
    • 8.3.2 China Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)
    • 8.3.5 India Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2021-2032)
  • 9.2 South America Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2021-2032)
  • 9.3 South America Onychomycosis (Tinea Unguium) Drug Market Size by Country
    • 9.3.1 South America Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country
    • 10.3.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Onychomycosis (Tinea Unguium) Drug Market Drivers
  • 11.2 Onychomycosis (Tinea Unguium) Drug Market Restraints
  • 11.3 Onychomycosis (Tinea Unguium) Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Onychomycosis (Tinea Unguium) Drug Industry Chain
  • 12.2 Onychomycosis (Tinea Unguium) Drug Upstream Analysis
  • 12.3 Onychomycosis (Tinea Unguium) Drug Midstream Analysis
  • 12.4 Onychomycosis (Tinea Unguium) Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Onychomycosis (Tinea Unguium) Drug. Industry analysis & Market Report on Onychomycosis (Tinea Unguium) Drug is a syndicated market report, published as Global Onychomycosis (Tinea Unguium) Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Onychomycosis (Tinea Unguium) Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo